ArticleBMC pharmacology & toxicology2025
Mechanistic decoding of triclosan-induced endometriosis via network toxicology, Mendelian randomization, and molecular docking.
Article in BMC pharmacology & toxicology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundTriclosan, a widely used environmental contaminant with endocrine-disrupting properties, has been increasingly implicated in female reproductive disorders. However, the potential mechanistic link between triclosan exposure and endometriosis remains poorly understood.
methodsAn integrative strategy combining network toxicology, Mendelian randomization (MR), and molecular docking was applied to explore the potential mechanistic association between triclosan and endometriosis. Toxicity and ADMET profiling of triclosan were performed using ProTox-3.0 and ADMETlab 2.0. Target prediction was conducted via STITCH and SwissTargetPrediction, while endometriosis-related genes were obtained from GeneCards, OMIM, and TTD. Common targets were subjected to PPI network construction and GO/KEGG enrichment analysis. MR analysis was performed to evaluate causality between IL1B expression and endometriosis risk. Molecular docking was used to validate the binding potential of triclosan to key proteins.
resultsA total of 19 overlapping genes were identified between triclosan- and endometriosis-related targets. PPI network analysis revealed IL1B, SRC, EGFR, and KDR as hub genes. Enrichment analysis indicated significant involvement in MAPK signaling, VEGF signaling, and endocrine-related pathways. MR analysis supported a potential causal relationship between IL1B and endometriosis (MR-Egger OR = 2.66, P < 0.05). Docking simulations demonstrated stable binding of triclosan to all four hub targets, with binding energies ranging from − 5.3 to − 5.9 kcal/mol.
conclusionThis study provides mechanistic insights into the potential role of triclosan in endometriosis development, highlighting IL1B as a possible causal mediator. These findings contribute to a better understanding of environmental risk factors in endometriosis and offer potential molecular targets for future research.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.